Exogenous Surfactant Through Nebulizer Mask on Clinical Outcomes in Covid-19 Patients

NCT04847375 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

COVID-19
Respiratory Distress Syndrome
Surface-Active Agents

Interventions

DRUG: exogenous surfactant

Sponsor

Shahid Beheshti University of Medical Sciences